Self-Monitoring Blood Glucose Devices Market Future Prospects and Forecast To 2030
The report " Self-Monitoring Blood Glucose Devices Market by Product (Blood Glucose Meter, Blood Glucose Testing Strips, Lancets, Others), by End Users( Hospitals, Clinics, Diagnostic Centers, Homecare), - Global Forecasts to 2030" The global Self-Monitoring Blood Glucose Devices Market is projected to reach USD 13.12 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 9.2% during the forecast period 2024-2030. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=36754 Competitive Dashboard: The prominent key players operating in the global Self-Monitoring Blood Glucose Devices Market are Abbott Laboratories (U.S.) ARKRAY, Inc. (Japan) Bayer AG (Germany) Dexcom, Inc. (U.S.) Hoffmann-La Roche Ltd (Switzerland) Johnson & Johnson (U.S.) Medtronic plc (U.S.) Nipro Diagnostics, Inc. (U.S.) Terumo Medical Corporation (U.S.). Regional Overview: The report also examines the ...